- Home
- TPB vs ALVO Comparison
TPB vs ALVO Comparison
Compare TPB & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TPB | ALVO |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Tobacco | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TPB | ALVO |
|---|---|---|
| Price | $60.48 | $5.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $115.00 | $8.00 |
| AVG Volume (30 Days) | 318.6K | ★ 971.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | ★ 45.33 | N/A |
| EPS | ★ 3.11 | N/A |
| Revenue | ★ $463,062,000.00 | N/A |
| Revenue This Year | $13.68 | $13.28 |
| Revenue Next Year | $11.32 | $18.63 |
| P/E Ratio | $19.51 | ★ $18.20 |
| Revenue Growth | ★ 28.39 | N/A |
| 52 Week Low | $58.57 | $2.94 |
| 52 Week High | $146.90 | $9.05 |
Technical Indicators
Market Signals| Indicator | TPB | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 25.58 | 72.50 |
| Support Level | N/A | $3.10 |
| Resistance Level | $91.03 | N/A |
| Average True Range (ATR) | 2.69 | 0.28 |
| MACD | -0.62 | 0.02 |
| Stochastic Oscillator | 13.19 | 93.31 |
Price Performance
Historical ComparisonAbout TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.